Using our first technology, bacterial interference, ConjuGon has developed C-1205. C-1205 is used for the prevention of catheter associated urinary tract infections, and is currently poised to enter Phase Ib clinical trials.
StartupBlink ranks the startup ecosystems of 100 countries and 1000 cities. Toggle between Countries/Cities ranking, search for a specific location, and download our PDF Ranking Report
  Go to 2019 Â
  Switch to Countries Board   Reset Â
*Upgrade to Pro Account to uncover the hidden values
1
2
3
4